Masters Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$60.6M Buy
+1,000,000
New +$58.3M 8.96% 11
2025
Q4
Sell
-1,000,000
Closed -$45.1M 83
2025
Q3
$45.1M Hold
1,000,000
7.24% 15
2025
Q2
$46.3M Sell
1,000,000
-1,000,000
-50% -$49.1M 8.91% 18
2025
Q1
$122M Hold
2,000,000
25.84% 3
2024
Q4
$113M Buy
+2,000,000
New +$112M 19.3% 6
2020
Q3
Sell
-600,000
Closed -$35.3M 56
2020
Q2
$35.3M Buy
600,000
+300,000
+100% +$17.9M 14.22% 8
2020
Q1
$16.7M Buy
+300,000
New +$18.3M 9.23% 11
2018
Q4
Sell
-1,527,000
Closed -$94.8M 59
2018
Q3
$94.8M Buy
1,527,000
+500,000
+49% +$29.7M 12.88% 14
2018
Q2
$56.8M Sell
1,027,000
-5,000
-0.5% -$270K 9.28% 15
2018
Q1
$65.3M Buy
1,032,000
+32,000
+3% +$2.06M 13.36% 19
2017
Q4
$61.3M Buy
1,000,000
+610,000
+156% +$38.2M 11.29% 21
2017
Q3
$24.9M Buy
+390,000
New +$22.8M 4.45% 43
2014
Q1
Sell
-1,000,000
Closed -$53.1M 57
2013
Q4
$53.1M Buy
+1,000,000
New +$50.9M 21.32% 11

Other funds holding BMY